12 Health Care Stocks Moving In Tuesday's Intraday Session
Portfolio Pulse from Benzinga Insights
Several healthcare stocks experienced significant movement during Tuesday's intraday session. Notable gainers included Axcella Health (AXLA), Tivic Health Systems (TIVC), Taysha Gene Therapies (TSHA), Akso Health Group (AHG), NeuroPace (NPCE), and P3 Health Partners (PIII). On the other hand, Longeveron Inc. - Subscription Right (LGVNR), T2 Biosystems (TTOO), Pulse Biosciences (PLSE), Capricor Therapeutics (CAPR), Ontrak (OTRKP), and PHAXIAM Therapeutics (PHXM) saw declines.
August 29, 2023 | 5:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Akso Health Group's shares rose 29.98% to $0.66.
The significant increase in Akso Health Group's stock price is likely to have a positive impact on its short-term performance.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Axcella Health's stock increased by 277.6% to $0.43 during Tuesday's session.
The significant increase in Axcella Health's stock price is likely to have a positive impact on its short-term performance.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
NeuroPace's shares moved upwards by 26.25% to $8.8.
The significant increase in NeuroPace's stock price is likely to have a positive impact on its short-term performance.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
P3 Health Partners' stock rose 24.82% to $1.76.
The significant increase in P3 Health Partners' stock price is likely to have a positive impact on its short-term performance.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Tivic Health Systems' stock moved upwards by 63.4% to $3.17.
The significant increase in Tivic Health Systems' stock price is likely to have a positive impact on its short-term performance.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Taysha Gene Therapies' shares moved upwards by 31.92% to $3.14.
The significant increase in Taysha Gene Therapies' stock price is likely to have a positive impact on its short-term performance.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Capricor Therapeutics' shares declined by 14.27% to $6.73.
The significant decrease in Capricor Therapeutics' stock price is likely to have a negative impact on its short-term performance.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Longeveron Inc. - Subscription Right's shares declined by 19.7% to $0.02.
The significant decrease in Longeveron Inc. - Subscription Right's stock price is likely to have a negative impact on its short-term performance.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Ontrak's shares fell 11.06% to $0.45.
The significant decrease in Ontrak's stock price is likely to have a negative impact on its short-term performance.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
PHAXIAM Therapeutics' shares declined by 10.89% to $0.52.
The significant decrease in PHAXIAM Therapeutics' stock price is likely to have a negative impact on its short-term performance.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Pulse Biosciences' shares declined by 15.32% to $4.81.
The significant decrease in Pulse Biosciences' stock price is likely to have a negative impact on its short-term performance.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
T2 Biosystems' shares decreased by 16.57% to $0.28.
The significant decrease in T2 Biosystems' stock price is likely to have a negative impact on its short-term performance.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100